The use of artificial intelligence in Breast Screening - NHS Test Beds Wave 2
The NHS East Midlands Radiology Consortium (EMRAD) are working closely with technology companies to develop artificial intelligence (AI) software with the aim of improving the NHS breast cancer screening process. Specifically, EMRAD is collaborating with Kheiron Medical to develop software that uses AI to detect abnormalities in mammograms. At the moment, AI is not being used in the breast screening programme but it may be in the future if it is shown to be accurate, safe and reliable.
We at TaoHealth Research & Implementation are the evaluators of the project and we are administering surveys across the East Midlands to understand the thoughts of NHS staff and members of the public about the use of artificial intelligence products in the breast screening pathway. The answers will help to inform the best ways to research the use of AI in breast screening and ensure that if these technologies are ever used with the public, patients and/or NHS staff, they are used in a way that benefits everybody involved.
The survey is now closed but if you would like to take part in future surveys as part of this project, please get in touch.
We at TaoHealth Research & Implementation are the evaluators of the project and we are administering surveys across the East Midlands to understand the thoughts of NHS staff and members of the public about the use of artificial intelligence products in the breast screening pathway. The answers will help to inform the best ways to research the use of AI in breast screening and ensure that if these technologies are ever used with the public, patients and/or NHS staff, they are used in a way that benefits everybody involved.
The survey is now closed but if you would like to take part in future surveys as part of this project, please get in touch.